WEBSITECHANGES

Website Changes

---

09/27/2019

Barriers to accrual and enrollment in brain tumor trials

---

09/25/2019

Medicenna Presents Promising Update from its MDNA55 Clinical Trial in Recurrent Glioblastoma at the Targeting Innate Immunity Congress

---

09/14/2019

DeAngelis named MSK physician-in-chief, chief medical officer

---

09/13/2019

Tocagen Reports Results of Toca 5 Phase 3 Trial in Recurrent Brain Cancer

---

09/11/2019

Frankly Speaking About Brain Tumors

---

09/11/2019

Publication Reports Clinical Efficacy of ONC201 in Expanded Access H3 K27M-mutant Glioma Patients

---

09/09/2019

Bristol-Myers Squibb`s Opdivo fails 3rd straight test in tough-to-treat brain cancer

---

09/09/2019

Novocure Announces 27 Presentations at the American Society for Radiation Oncology 2019 Annual Meeting

---

08/30/2019

Musella Foundation awards a pediatric brain tumor research grant!

---

08/15/2019

DelMar Pharmaceuticals Reports Updated Results on Twenty Patients from the Phase 2 Clinical Trial of VAL-083 as First-Line Treatment in Newly-Diagnosed MGMT-Unmethylated Glioblastoma MultiForme (GBM)

---

08/15/2019

Attend an Optune Open House

---

08/03/2019

Validation of an effective implantable pump-infusion system for chronic convection-enhanced delivery of intracerebral topotecan in a large animal model.

---

08/03/2019

Young adults diagnosed with high grade gliomas: Patterns of care, outcomes, and impact on employment.

---

07/29/2019

Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy.

---

07/29/2019

Long-term survival in patients with recurrent glioblastoma treated with bevacizumab: a multicentric retrospective study.

---

07/29/2019

Valerie Harper to stay out of hospice care, husband says

---

07/26/2019

Musella Foundation Brain Tumor Copay Program has reopened!

---

07/20/2019

A Randomized Double-Blind Placebo-Controlled Phase 2 Trial Of Dendritic Cell Vaccine ICT-107 In Newly Diagnosed Patients With Glioblastoma

---

07/19/2019

Study hints at why an aggressive form of brain cancer is hard to treat

---

07/19/2019

A New Method for Ethical and Efficient Evidence Generation for Off-Label Medication Use in Oncology (A Case Study in Glioblastoma)

---

07/18/2019

Medicare Releases Final Local Coverage Determination Providing Coverage of Optune® for Newly Diagnosed Glioblastoma

---

07/17/2019

ImmunoCellular Therapeutics Announces Asset Purchase Agreement with Private Biotechnology Company

---

07/17/2019

Electricity helps control man’s brain tumor

---

07/16/2019

GBM Awareness Day This Wednesday July 17th!

---

07/16/2019

Neoadjuvant Anti-PD-1 Immunotherapy Leads to Survival Benefit in Recurrent Glioblastoma

---